RecruitingNot ApplicableNCT04864080

Transdiagnostic Cognitive Biomarkers

Sponsor

University of Minnesota

Enrollment

48 participants

Start Date

Apr 11, 2022

Study Type

INTERVENTIONAL

Conditions

Pain Depression

Summary

The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using online cognitive tests to look for brain-based markers (biomarkers) of pain and depression, aiming to better understand how these conditions affect thinking and problem-solving. **You may be eligible if...** - For the healthy control group: you have access to the online study platform and are 18 or older - For the pain/depression group: you are experiencing chronic pain or depression and are 18 or older **You may NOT be eligible if...** - You are under 18 years old - You do not speak English - You are pregnant (for the pain/depression group) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.